Cardiosonic
Tel Aviv · Founded 2009
About Cardiosonic
Cardiosonic develops pioneering solutions for transluminal high-intensity ultrasound ablation. It has developed a high intensity, non-focused therapeutic ultrasound catheter and control system for remote tissue ablation for the treatment of hypertension by Renal Denervation. The company has tested the TIVUSTM system in extensive bench and animal studies and recently initiated a pilot human clinical trial.
Company Facts
- Founded: 2009
- Legal name: Cardiosonic, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2012)
- Website: cardiosonic.co.il
Canonical: https://fsome.com/organization/cardiosonic-8418056 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.